Overview - The medicinal value of leeches is significant, with active components playing a crucial role in treating thrombosis and liver diseases. The demand for leeches in the pharmaceutical market has rapidly increased due to the aging population and rising chronic disease rates in China. Additionally, the growing health awareness among the public has led to broader applications of leeches in health foods and skincare, resulting in a year-on-year increase in market demand. The market size of the leech farming industry in China is projected to reach 1.439 billion yuan in 2024, representing a growth of 2.93% [1][9]. Market Policies - The Chinese government places high importance on the development of the aquaculture industry, including leech farming, and has issued several supportive policies to create a favorable environment for industry growth. These include guidelines for rural revitalization, traditional food production, and ecological aquaculture development [4][6]. Industry Chain - The leech farming industry in China has developed a comprehensive industry chain that includes seedling breeding, feed supply, farming, product processing, and market sales. The upstream includes seedling, feed, veterinary drugs, and farming equipment, while the downstream focuses on processing leeches for medicinal and health products. Recent advancements in breeding technology and feed industry development have improved seedling quality and stability, enhancing the overall industry chain [7]. Current Development - The leech farming industry is experiencing continuous expansion driven by increasing market demand in the pharmaceutical sector. The market size is expected to reach 1.439 billion yuan in 2024, with a year-on-year growth of 2.93% [9]. Competitive Landscape - The leech farming industry in China is characterized by a low entry barrier, resulting in a large number of participants, primarily individual farmers and small farms. As of June 30, 2025, over 50% of registered leech farming enterprises have a registered capital of less than 1 million yuan, while those with over 50 million yuan account for less than 1% [11]. Representative Companies - **Huazhi Pharmaceutical (Yunnan) Co., Ltd.** focuses on the research, development, and production of medicinal leeches and their derivatives. The company operates high-density and ecological farming bases in Yunnan and Guangxi, supplying 80% of the national market [14]. - **Guangxi Kekan Technology Group Co., Ltd.** specializes in the breeding and research of the Fiery Leech. The company has invested over 30 million yuan in establishing a large-scale breeding and demonstration base, producing over 30 tons of live leeches annually [16][17]. Development Trends - The future of leech farming is expected to see the widespread adoption of intelligent farming technologies, enhancing efficiency and quality through automated feeding and monitoring systems. Additionally, genetic breeding techniques will improve growth rates and disease resistance, while market competition will likely lead to resource consolidation among larger enterprises, promoting large-scale and intensive farming practices [22].

Core Insights - The article highlights the increasing focus on cardiovascular health among affluent individuals in the U.S., driven by rising living standards [2] - The market for cardiovascular health supplements in the U.S. has surpassed $10 billion and is growing at an annual rate of 5-8% [2] - The product "XinNaoHuoSu" capsules are tailored for high-end consumers, featuring five core ingredients that provide comprehensive care for cardiovascular health [2] Product Features - The five core ingredients of XinNaoHuoSu capsules include Hirudin, Nattokinase, Phosphatidylserine, Earthworm enzyme, and L-Theanine, each contributing uniquely to cardiovascular health [2] - Hirudin acts as a powerful anticoagulant, preventing blood clots and reducing the risk of cardiovascular diseases [3] - Nattokinase serves as a "vascular scavenger," breaking down fibrin in blood clots and enhancing the body's fibrinolytic system [3] - Phosphatidylserine is crucial for brain health, improving cognitive function and potentially delaying age-related cognitive decline [4] - Earthworm enzyme aids in dissolving blood clots and improving blood circulation, thus enhancing the quality of life for seniors [4] - L-Theanine helps regulate emotions, reduce stress, and improve sleep quality, which is vital for cardiovascular health [6] Quality Assurance - XinNaoHuoSu capsules are produced under strict quality control, adhering to the highest U.S. standards, and are certified by the FDA and other international quality management systems [6] - The product has received endorsements from notable longevity figures, enhancing its credibility and appeal in the high-end health market [7] - Clinical studies from authoritative institutions support the efficacy of XinNaoHuoSu capsules in preventing and improving cardiovascular diseases [7]